Patients' findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT

Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):791-795. doi: 10.1007/s00259-021-05652-1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • COVID-19*
  • Fluorodeoxyglucose F18*
  • Humans
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • SARS-CoV-2
  • Vaccination / adverse effects

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18